Liminatus Pharma Inc (LIMN) Annual Balance Sheets

Annual · GAAP · USD millions
Access LIMN quarterly Balance Sheets →
Reviewing balance sheet data across recent quarters allows users to assess how Liminatus Pharma Inc manages assets, liabilities, and equity through different cycles.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
Assets
Cash & cash equivalent0.34
Cash & Short-term Investments0.00
Prepaid Expense And Other Assets Current0.16
Total Current Assets0.50
Equipment/Property/Plant Net0.01
Total Assets0.51
Liabilities
Accounts Payable and Accrued Liabilities, Current LI0.58
Short-term Debt DE11.44
Other Liabilities, Current8.27
Total Current Liabilities10.30
Total Long-term Debt0.00
Other liabilities, Noncurrent0.03
Accrued Interest Current0.20
Deferred Underwriting Fees Payable In Cash Current0.50
Total Liabilities10.33
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock29.05
Retained Earnings / Accumulated Deficit-38.87
Defined Benefit Plan and Other0.03
Other Equity-0.03
Common Stockholder's Equity-9.81
Total Stockholder's Equity-9.81
Liabilities & Stockholder's Equity0.51
4 historic quarters locked

Sign in to unlock the full Liminatus Pharma Inc balance sheet history.

About Liminatus Pharma Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-037933

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License